<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:48:26Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8755039" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8755039</identifier>
        <datestamp>2022-01-14</datestamp>
        <setSpec>ajcn</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Am J Clin Nutr</journal-id>
              <journal-id journal-id-type="iso-abbrev">Am J Clin Nutr</journal-id>
              <journal-id journal-id-type="publisher-id">ajcn</journal-id>
              <journal-title-group>
                <journal-title>The American Journal of Clinical Nutrition</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0002-9165</issn>
              <issn pub-type="epub">1938-3207</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8755039</article-id>
              <article-id pub-id-type="pmcid">PMC8755039</article-id>
              <article-id pub-id-type="pmc-uid">8755039</article-id>
              <article-id pub-id-type="pmid">34582545</article-id>
              <article-id pub-id-type="pmid">34582545</article-id>
              <article-id pub-id-type="doi">10.1093/ajcn/nqab287</article-id>
              <article-id pub-id-type="publisher-id">nqab287</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Research Communications</subject>
                  <subj-group subj-group-type="category-toc-heading">
                    <subject>Lipids</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="category-taxonomy-collection">
                  <subject>AcademicSubjects/MED00060</subject>
                  <subject>AcademicSubjects/MED00160</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effects of a low-carbohydrate diet on insulin-resistant dyslipoproteinemia—a
randomized controlled feeding trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7088-9859</contrib-id>
                  <name>
                    <surname>Ebbeling</surname>
                    <given-names>Cara B</given-names>
                  </name>
                  <aff><institution>New Balance Foundation Obesity Prevention Center, Boston Children's
Hospital</institution>, <addr-line>Boston, MA</addr-line>, <country country="US">USA</country></aff>
                  <aff><institution>Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>,
<country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Knapp</surname>
                    <given-names>Amy</given-names>
                  </name>
                  <aff><institution>Department of Biology, Framingham State University</institution>,
<addr-line>Framingham, MA</addr-line>, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Johnson</surname>
                    <given-names>Ann</given-names>
                  </name>
                  <aff><institution>Department of Food and Nutrition, Framingham State
University</institution>, <addr-line>Framingham, MA</addr-line>, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wong</surname>
                    <given-names>Julia M W</given-names>
                  </name>
                  <aff><institution>New Balance Foundation Obesity Prevention Center, Boston Children's
Hospital</institution>, <addr-line>Boston, MA</addr-line>, <country country="US">USA</country></aff>
                  <aff><institution>Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>,
<country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Greco</surname>
                    <given-names>Kimberly F</given-names>
                  </name>
                  <aff><institution>Institutional Centers for Clinical and Translational Research, Boston
Children's Hospital</institution>, <addr-line>Boston, MA</addr-line>, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ma</surname>
                    <given-names>Clement</given-names>
                  </name>
                  <aff><institution>Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>,
<country country="US">USA</country></aff>
                  <aff><institution>Dana-Farber/Boston Children's Cancer and Blood Disorders
Center</institution>, <addr-line>Boston, MA</addr-line>, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6283-0980</contrib-id>
                  <name>
                    <surname>Mora</surname>
                    <given-names>Samia</given-names>
                  </name>
                  <aff><institution>Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>,
<country country="US">USA</country></aff>
                  <aff><institution>Center for Lipid Metabolomics, Divisions of Preventive and Cardiovascular
Medicine, Brigham and Women's Hospital</institution>, <addr-line>Boston,
MA</addr-line>, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3307-8544</contrib-id>
                  <name>
                    <surname>Ludwig</surname>
                    <given-names>David S</given-names>
                  </name>
                  <!--david.ludwig@childrens.harvard.edu-->
                  <aff><institution>New Balance Foundation Obesity Prevention Center, Boston Children's
Hospital</institution>, <addr-line>Boston, MA</addr-line>, <country country="US">USA</country></aff>
                  <aff><institution>Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>,
<country country="US">USA</country></aff>
                  <xref rid="cor1" ref-type="corresp"/>
                </contrib>
              </contrib-group>
              <author-notes>
                <corresp id="cor1">Address correspondence to DSL (e-mail: <email>david.ludwig@childrens.harvard.edu</email>).</corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <month>1</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2021-09-28">
                <day>28</day>
                <month>9</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>28</day>
                <month>9</month>
                <year>2021</year>
              </pub-date>
              <volume>115</volume>
              <issue>1</issue>
              <fpage>154</fpage>
              <lpage>162</lpage>
              <history>
                <date date-type="received">
                  <day>26</day>
                  <month>7</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>10</day>
                  <month>8</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2021. Published by Oxford University Press on behalf of
the American Society for Nutrition.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits
non-commercial re-use, distribution, and reproduction in any medium, provided the
original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
                </license>
              </permissions>
              <self-uri xlink:href="nqab287.pdf"/>
              <abstract>
                <title>ABSTRACT</title>
                <sec id="abs1">
                  <title>Background</title>
                  <p>Carbohydrate restriction shows promise for diabetes, but concerns regarding high
saturated fat content of low-carbohydrate diets limit widespread adoption.</p>
                </sec>
                <sec id="abs2">
                  <title>Objectives</title>
                  <p>This preplanned ancillary study aimed to determine how diets varying widely in
carbohydrate and saturated fat affect cardiovascular disease (CVD) risk factors during
weight-loss maintenance.</p>
                </sec>
                <sec id="abs3">
                  <title>Methods</title>
                  <p>After 10–14% weight loss on a run-in diet, 164 participants (70% female; BMI =
32.4 ± 4.8 kg/m<sup>2</sup>) were randomly assigned to 3 weight-loss maintenance diets
for 20 wk. The prepared diets contained 20% protein and differed 3-fold in carbohydrate
(Carb) and saturated fat as a proportion of energy (Low-Carb: 20% carbohydrate, 21%
saturated fat; Moderate-Carb: 40%, 14%; High-Carb: 60%, 7%). Fasting plasma samples were
collected prerandomization and at 20 wk. Lipoprotein insulin resistance (LPIR) score was
calculated from triglyceride-rich, high-density, and low-density lipoprotein particle
(TRL-P, HDL-P, LDL-P) sizes and subfraction concentrations (large/very large TRL-P,
large HDL-P, small LDL-P). Other outcomes included lipoprotein(a), triglycerides, HDL
cholesterol, LDL cholesterol, adiponectin, and inflammatory markers. Repeated measures
ANOVA was used for intention-to-treat analysis.</p>
                </sec>
                <sec id="abs4">
                  <title>Results</title>
                  <p>Retention was 90%. Mean change in LPIR (scale 0–100) differed by diet in a
dose-dependent fashion: Low-Carb (–5.3; 95% CI: –9.2, –1.5), Moderate-Carb (–0.02; 95%
CI: –4.1, 4.1), High-Carb (3.6; 95% CI: –0.6, 7.7), <italic toggle="yes">P</italic> = 0.009. Low-Carb
also favorably affected lipoprotein(a) [–14.7% (95% CI: –19.5, –9.5), –2.1 (95% CI:
–8.2, 4.3), and 0.2 (95% CI: –6.0, 6.8), respectively; <italic toggle="yes">P</italic> = 0.0005],
triglycerides, HDL cholesterol, large/very large TRL-P, large HDL-P, and adiponectin.
LDL cholesterol, LDL-P, and inflammatory markers did not differ by diet.</p>
                </sec>
                <sec id="abs5">
                  <title>Conclusions</title>
                  <p>A low-carbohydrate diet, high in saturated fat, improved insulin-resistant
dyslipoproteinemia and lipoprotein(a), without adverse effect on LDL cholesterol.
Carbohydrate restriction might lower CVD risk independently of body weight, a
possibility that warrants study in major multicentered trials powered on hard outcomes.
The registry is available through <ext-link xlink:href="https://clinicaltrials.gov/" ext-link-type="uri">ClinicialTrials.gov</ext-link>: <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT02068885" ext-link-type="uri">https://clinicaltrials.gov/ct2/show/NCT02068885</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="keywords">
                <kwd>low-carbohydrate diet</kwd>
                <kwd>saturated fat</kwd>
                <kwd>cardiovascular disease risk factors</kwd>
                <kwd>obesity</kwd>
                <kwd>macronutrients</kwd>
                <kwd>dietary trial</kwd>
              </kwd-group>
              <funding-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute of Diabetes and Digestive and Kidney
Diseases</institution>
                      <institution-id institution-id-type="DOI">10.13039/100000062</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K24DK082730</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Heart, Lung, and Blood Institute</institution>
                      <institution-id institution-id-type="DOI">10.13039/100000050</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K24HL136852</award-id>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="9"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1">
              <title>Introduction</title>
              <p>For nearly a half century, advice to reduce saturated fat intake has been a major focus of
dietary guidelines for public health and medical nutrition therapy (<xref rid="bib1" ref-type="bibr">1</xref>). This advice is based in part on evidence from clinical trials
showing that saturated fat increases plasma LDL cholesterol (<xref rid="bib2" ref-type="bibr">2</xref>), a major risk factor for cardiovascular disease (CVD). Replacing
saturated with unsaturated fat lowers LDL cholesterol in trials and reduces risk of
cardiovascular and total mortality in cohort studies (<xref rid="bib3" ref-type="bibr">3</xref>).</p>
              <p>Conversely, when saturated fat is replaced by carbohydrate, particularly from processed
sources (<xref rid="bib4" ref-type="bibr">4</xref>), reducing intake does not decrease risk
(<xref rid="bib3" ref-type="bibr">3</xref>) and can have adverse effects on components of
the metabolic syndrome, including high triglycerides, low HDL cholesterol, and other risk
factors related to insulin resistance (<xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>). Low-carbohydrate diets, with saturated fat content
far exceeding current guidelines, have become popular for diabetes management (<xref rid="bib7" ref-type="bibr">7</xref>) based on preliminary evidence of efficacy (<xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>), albeit
with concern for the potential of saturated fat to raise LDL cholesterol and consequently
CVD risk. However, LDL cholesterol does not capture potentially important diet effects on
CVD risk from insulin-resistant dyslipoproteinemia (<xref rid="bib10" ref-type="bibr">10</xref>). Indeed, there is broad consensus regarding the need to assess multiple
biomarkers beyond LDL cholesterol to clarify the relation between diet and CVD (<xref rid="bib11" ref-type="bibr">11</xref>).</p>
              <p>The aim of this study was to compare the effects on novel and conventional CVD risk factors
of low-, moderate-, and high-carbohydrate diets varying in saturated fat content in a manner
reflective of how these diets are typically consumed. We hypothesized that the
low-carbohydrate diet would improve lipoprotein insulin resistance (LPIR) score, a metabolic
marker that captures incipient effects of insulin resistance on lipoprotein metabolism and
has been robustly associated with incident type 2 diabetes and premature coronary heart
disease (<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib12" ref-type="bibr">12–15</xref>). To enhance dietary adherence, we provided
participants with fully prepared meals throughout the study.</p>
            </sec>
            <sec sec-type="methods" id="sec2">
              <title>Methods</title>
              <sec id="sec2-1">
                <title>Parent study</title>
                <p>The Framingham State Food Study was a randomized controlled feeding trial conducted from
August 2014 to May 2017, with the primary aim of examining macronutrient effects on energy
metabolism (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>). Briefly, the study comprised Run-In and Test phases (<xref rid="fig1" ref-type="fig"><bold>Figure 1</bold></xref>). During the Run-In phase, we restricted energy
intake to promote 12 ± 2% weight loss over 9–10 wk and randomly assigned participants who
achieved the target weight loss to low-, moderate-, and high-carbohydrate Test diets
(Low-Carb, Moderate-Carb, High-Carb). The method for random assignment is presented in
<bold><xref rid="sup1" ref-type="supplementary-material">Supplemental
Methods</xref></bold>. During the 20-wk Test phase, we adjusted energy intake to
maintain weight within ±2 kg of that achieved after weight loss and immediately prior to
randomization. A partnership with Sodexo, the food service contractor at Framingham State
University, was established for implementing the feeding protocol on campus (<xref rid="bib17" ref-type="bibr">17</xref>). The institutional review board at Boston
Children's Hospital approved the study protocol. Participants provided written informed
consent. The protocol history is presented in the <bold><xref rid="sup1" ref-type="supplementary-material">Supplemental Material</xref></bold>.
Results for the primary outcome were previously reported, that total energy expenditure
was higher (∼200 kcal/d) on the low- compared with high-carbohydrate diet (<xref rid="bib18" ref-type="bibr">18</xref>).</p>
                <fig position="float" id="fig1">
                  <label>FIGURE 1</label>
                  <caption>
                    <p>Study design.</p>
                  </caption>
                  <graphic xlink:href="nqab287fig1" position="float"/>
                </fig>
                <p>We utilized the infrastructure of this trial to conduct a preplanned ancillary study
focused on clinically relevant CVD risk factors. All individual outcomes were prespecified
except lipoprotein(a) [Lp(a)], which was measured after review of initial data. The
composite LPIR score was calculated from prespecified outcomes. We analyzed blood samples
collected following an overnight fast at the following time points: pre-weight-loss (PRE),
start of the trial (START, post-weight-loss, prerandomization), and end of the Test phase
(END).</p>
              </sec>
              <sec id="sec2-2">
                <title>Participants</title>
                <p>We enrolled adults aged 18 to 65 y with BMI ≥25 kg/m<sup>2</sup>, excluding those with
known CVD or diabetes. Additional eligibility criteria are listed in <bold><xref rid="sup1" ref-type="supplementary-material">Supplemental Table 1</xref></bold>. At
the time of enrollment, we collected demographic information including sex, date of birth,
race (white, black, Asian, multiple, or other), and ethnic group (Hispanic or
non-Hispanic).</p>
              </sec>
              <sec id="sec2-3">
                <title>Diets</title>
                <p>The hypocaloric Run-In diet contained 45% of total energy from carbohydrate, 35% from
fat, and 25% from protein. The Test diets, with protein controlled at 20% of total energy,
were designed to vary in proportions of carbohydrate and fat by 3-fold (Low-Carb: 20%,
60%; Moderate-Carb: 40%, 40%; High-Carb: 60%, 20%). Saturated fat comprised 35% of total
fat for each diet, also with a 3-fold difference across diets when expressed as a
proportion of total energy (21%, 14%, 7%, respectively). Monounsaturated fat was 25%, 16%,
and 8%, and polyunsaturated fat was 11%, 9%, and 5% as a proportion of total energy. Daily
dietary fiber was 25, 30, and 35 g/2000 kcal, respectively, with added sugar relative to
total carbohydrate controlled at 15% across diets. Glycemic load was 28, 80, and
135 g/2000 kcal, respectively. Additional details regarding dietary interventions are
presented in the <xref rid="sup1" ref-type="supplementary-material">Supplemental
Material</xref>, including nutrient profiles and sample menus for the Test diets in
<bold><xref rid="sup1" ref-type="supplementary-material">Supplemental Tables 2 and
3</xref></bold>.</p>
              </sec>
              <sec id="sec2-4">
                <title>Outcomes</title>
                <p>Research personnel assessing outcomes for this report were blinded to random group
assignment. Lipoprotein particle subfractions were measured by proton NMR spectroscopy
using the LipoProfile-4 algorithm (LabCorp, Inc.) (<xref rid="bib19" ref-type="bibr">19</xref>). Outcomes included mean particle diameters [triglyceride-rich lipoprotein
particles (TRL-P), high-density lipoprotein particles (HDL-P), low-density lipoprotein
particles (LDL-P)] and subclass particle concentrations (sum of large and very large
TRL-P, large HDL-P, small LDL-P, large LDL-P). The LIPR test is calculated from 6
component metabolic markers of insulin-resistant dyslipoproteinemia, including particle
diameters (TRL-P, HDL-P, LDL-P) and concentrations (sum of large and very large TRL-P,
large HDL-P, small LDL-P) (<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib15" ref-type="bibr">15</xref>). This score is more strongly related to insulin
resistance than each of the individual components (<xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib20" ref-type="bibr">20</xref>) and has been associated with
incident type 2 diabetes mellitus (<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib20" ref-type="bibr">20</xref>) and
coronary heart disease (<xref rid="bib13" ref-type="bibr">13</xref>). We obtained
NMR-derived plasma concentrations of triglycerides, HDL cholesterol, and LDL cholesterol,
and also measured serum concentrations by direct enzymatic assays (Roche Diagnostics)
using samples from the same blood draw. Correlations between the 2 methods exceeded
<italic toggle="yes">r</italic> = 0.9 (<italic toggle="yes">P</italic> &lt; 0.001) for all variables. Lp(a) was
measured by turbidimetric assay insensitive to the number of kringle IV type-2 repeats
(Roche Diagnostics) (<xref rid="bib21" ref-type="bibr">21</xref>). We measured serum
high-sensitivity C-reactive protein (hsCRP) using an immunoturbidimetric assay (Roche
Diagnostics) and IL-6 using an ultrasensitive ELISA (R&amp;D Systems). We measured total
and high molecular weight (HMW) adiponectin using an ELISA (R&amp;D Systems). We measured
resting blood pressure 3 times by auscultation, averaging the second 2 measurements for
analysis.</p>
              </sec>
              <sec id="sec2-5">
                <title>Statistical analyses</title>
                <p>Patient characteristics at PRE and study outcomes at each time point were summarized with
descriptive statistics (mean and SD for continuous variables, median and IQR for skewed
continuous variables, count and percentage for categorical variables). An unadjusted
repeated-measures ANOVA was used to evaluate change in LPIR from START to END in the
intention-to-treat sample. Secondary outcomes were analyzed using the same model. A post
hoc power analysis and rationale for fitting unadjusted models are presented in the <xref rid="sup1" ref-type="supplementary-material">Supplemental Methods</xref>. A partial
<italic toggle="yes">F</italic> test was used to assess overall significance of diet in the model,
and <italic toggle="yes">t</italic> tests were used to assess changes within each arm. Post hoc
pairwise comparison between Low-Carb and High-Carb was equivalent to a test for linear
trend across the 3 diets, recognizing equal increments in carbohydrate content across the
3 diets. Skewed variables were log- or log-plus-one–transformed for analysis. Least
squares means and SEs were back-transformed to the original units for reporting.
Studentized residual plots and Cook's distance were used to identify outliers and
influential observations with potential to impact the validity of results. Pearson
correlation coefficients (or Spearman coefficients for skewed variables) were calculated
using PRE data to construct a correlation matrix of LPIR, components of LPIR, TRL
triglycerides, total triglycerides, HDL cholesterol, and apoA-I (derived from NMR data).
Two-sided <italic toggle="yes">P</italic> values ≤0.05 were considered statistically significant.
Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc.).</p>
              </sec>
              <sec id="sec2-6">
                <title>Patient and public involvement</title>
                <p>No patients were involved in setting the research question or the outcome measures, nor
were they involved in developing plans for design or implementation of the study. Study
participants received a written summary of their clinically relevant results.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3">
              <title>Results</title>
              <sec id="sec3-1">
                <title>Participants</title>
                <p><xref rid="fig2" ref-type="fig"><bold>Figure 2</bold></xref> depicts the flow of participants through the trial, and <xref rid="tbl1" ref-type="table"><bold>Table 1</bold></xref> lists participant characteristics at PRE.
Retention rate was 90%, with 148 participants completing the study and 147 included in the
analysis [after a priori exclusion of 1 participant who developed hypothyroidism (<xref rid="bib16" ref-type="bibr">16</xref>)]. Weight loss during the Run-In phase (mean ± SD)
was 10.5% ± 1.7% for 164 participants randomly assigned to a diet group (and, similarly,
10.5% ± 1.6% for <italic toggle="yes">n</italic> = 147 completers). Mean change in body weight for the
full cohort from START to END was –0.55 kg (–4 g/d), with no difference between diet
groups (<italic toggle="yes">P</italic> = 0.79). Details of adverse events, which did not differ by
diet group, are included in <bold><xref rid="sup1" ref-type="supplementary-material">Supplemental Table 4</xref></bold>.</p>
                <fig position="float" id="fig2">
                  <label>FIGURE 2</label>
                  <caption>
                    <p>Participant flow. PCP, primary care practitioner.</p>
                  </caption>
                  <graphic xlink:href="nqab287fig2" position="float"/>
                </fig>
                <table-wrap position="float" id="tbl1">
                  <label>TABLE 1</label>
                  <caption>
                    <p>Pre-weight-loss characteristics of study participants in the Framingham State Food
Study<sup><xref rid="tb1fn1" ref-type="table-fn">1</xref></sup></p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1">Characteristic</th>
                        <th align="center" rowspan="1" colspan="1">All randomized (<italic toggle="yes">n</italic> = 164)</th>
                        <th align="center" rowspan="1" colspan="1">Completers<sup><xref rid="tb1fn2" ref-type="table-fn">2</xref></sup> (<italic toggle="yes">n</italic> = 147)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">Sex</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Male</td>
                        <td rowspan="1" colspan="1">49 (29.9)</td>
                        <td rowspan="1" colspan="1">45 (30.6)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Female</td>
                        <td rowspan="1" colspan="1">115 (70.1)</td>
                        <td rowspan="1" colspan="1">102 (69.4)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Ethnic group</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Hispanic</td>
                        <td rowspan="1" colspan="1">25 (15.2)</td>
                        <td rowspan="1" colspan="1">21 (14.3)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Non-Hispanic</td>
                        <td rowspan="1" colspan="1">139 (84.8)</td>
                        <td rowspan="1" colspan="1">126 (85.7)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Racial group</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">White</td>
                        <td rowspan="1" colspan="1">128 (78.0)</td>
                        <td rowspan="1" colspan="1">115 (78.2)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Black</td>
                        <td rowspan="1" colspan="1">17 (10.4)</td>
                        <td rowspan="1" colspan="1">16 (10.9)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Asian</td>
                        <td rowspan="1" colspan="1">5 (3.0)</td>
                        <td rowspan="1" colspan="1">5 (3.4)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Unknown/other</td>
                        <td rowspan="1" colspan="1">14 (8.5)</td>
                        <td rowspan="1" colspan="1">11 (7.5)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Age at first visit, y</td>
                        <td rowspan="1" colspan="1">35.0 (23.6–50.1)</td>
                        <td rowspan="1" colspan="1">35.7 (24.0–51.2)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Weight, kg</td>
                        <td align="center" rowspan="1" colspan="1">91.5 ± 18.2</td>
                        <td align="center" rowspan="1" colspan="1">91.3 ± 18.3</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Height, cm</td>
                        <td align="center" rowspan="1" colspan="1">167.7 ± 10.0</td>
                        <td align="center" rowspan="1" colspan="1">167.9 ± 10.1</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">BMI, kg/m<sup>2</sup></td>
                        <td align="center" rowspan="1" colspan="1">32.4 ± 4.8</td>
                        <td align="center" rowspan="1" colspan="1">32.2 ± 4.8</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">BMI category</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Overweight (≥25 to &lt;30)</td>
                        <td rowspan="1" colspan="1">65 (39.6)</td>
                        <td rowspan="1" colspan="1">63 (42.9)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Obesity (≥<inline-formula><tex-math id="TM0001" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$30$\end{document}</tex-math></inline-formula>)</td>
                        <td rowspan="1" colspan="1">99 (60.4)</td>
                        <td rowspan="1" colspan="1">84 (57.1)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Body fat (% total mass)</td>
                        <td align="center" rowspan="1" colspan="1">40.9 ± 6.2</td>
                        <td align="center" rowspan="1" colspan="1">40.7 ± 6.4</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Blood pressure, mmHg</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Systolic</td>
                        <td align="center" rowspan="1" colspan="1">123.3 ± 10.5</td>
                        <td align="center" rowspan="1" colspan="1">123.7 ± 10.7</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Diastolic</td>
                        <td align="center" rowspan="1" colspan="1">76.5 ± 7.3</td>
                        <td align="center" rowspan="1" colspan="1">76.6 ± 7.4</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Blood lipids</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Triglycerides, mg/dL</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">112.0 (81.0–156.0)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Total cholesterol, mg/dL</td>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">166.4 ± 34.3</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">HDL-C, mg/dL</td>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">51.1 ± 11.7</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Non-HDL-C, mg/dL</td>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">115.3 ± 32.6</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">LDL-C, mg/dL</td>
                        <td rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">92.2 ± 25.9</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Lipoprotein(a),<sup><xref rid="tb1fn3" ref-type="table-fn">3</xref></sup>
mg/dL</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1">10.7 (5.9–34.0)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tb1fn1">
                      <label>1</label>
                      <p>For categorical variables, values are frequency (%). For continuous variables,
values are mean ± SD if normally distributed and median (IQR) if skewed. HDL-C, HDL
cholesterol; LDL-C, LDL cholesterol.</p>
                    </fn>
                    <fn id="tb1fn2">
                      <label>2</label>
                      <p>Among the completers (<italic toggle="yes">n</italic> = 148), 1 participant developed
hypothyroidism and was an a priori exclusion from analyses of all outcome variables
in this report.</p>
                    </fn>
                    <fn id="tb1fn3">
                      <label>3</label>
                      <p>Lipoprotein(a) was missing for 1 participant at pre-weight-loss.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec3-2">
                <title>Outcomes</title>
                <p><bold><xref rid="sup1" ref-type="supplementary-material">Supplemental Table 5</xref></bold> shows descriptive data at PRE and START for study outcomes, and <xref rid="tbl2" ref-type="table"><bold>Table 2</bold></xref> presents changes from START to
END. <xref rid="fig3" ref-type="fig"><bold>Figure 3</bold></xref> depicts percentage
change from START to END for LPIR, Lp(a), and LDL cholesterol; and <bold><xref rid="sup1" ref-type="supplementary-material">Supplemental Figure 1</xref></bold>
depicts individual participant data for these variables.</p>
                <fig position="float" id="fig3">
                  <label>FIGURE 3</label>
                  <caption>
                    <p>Change in LPIR, Lp(a), and LDL-C by diet group in the Framingham State Food Study.
LDL-C increased in all groups, without difference by group, potentially reflecting
adaptation to increased energy intake in the Test phase. The sample included
<italic toggle="yes">n</italic> = 53 in Low-Carb, <italic toggle="yes">n</italic> = 48 in Moderate-Carb, and
<italic toggle="yes">n</italic> = 46 in High-Carb. Because data were missing for 2 participants
in Moderate-Carb, the Lp(a) analysis included <italic toggle="yes">n</italic> = 46 for this group.
Means were constructed and compared using unadjusted repeated measures ANOVA. A
partial <italic toggle="yes">F</italic> test was used to assess overall significance of diet in the
repeated measures model. Lp(a) was log-transformed for analysis. For visualization,
percentage change (mean with SE) was calculated from data in <xref rid="tbl2" ref-type="table">Table 2</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplemental Table 5</xref>. LDL-C, LDL cholesterol; Lp(a), lipoprotein(a); LPIR,
lipoprotein insulin resistance.</p>
                  </caption>
                  <graphic xlink:href="nqab287fig3" position="float"/>
                </fig>
                <table-wrap position="float" id="tbl2">
                  <label>TABLE 2</label>
                  <caption>
                    <p>Changes in outcome variables by diet group during the Test phase of the Framingham
State Food Study<sup><xref rid="tb2fn1" ref-type="table-fn">1</xref></sup></p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1"/>
                        <th colspan="4" align="center" rowspan="1">Change (END − START) by diet group</th>
                        <th colspan="2" align="center" rowspan="1">Linear trend across diet groups</th>
                      </tr>
                      <tr>
                        <th rowspan="1" colspan="1">Variable</th>
                        <th align="center" rowspan="1" colspan="1">Low-Carb (<italic toggle="yes">n</italic> = 53)</th>
                        <th align="center" rowspan="1" colspan="1">Moderate-Carb (<italic toggle="yes">n</italic> = 48)</th>
                        <th align="center" rowspan="1" colspan="1">High-Carb (<italic toggle="yes">n</italic> = 46)</th>
                        <th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value<sup><xref rid="tb2fn2" ref-type="table-fn">2</xref></sup></th>
                        <th align="center" rowspan="1" colspan="1">Low-Carb − High-Carb</th>
                        <th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value<sup><xref rid="tb2fn3" ref-type="table-fn">3</xref></sup></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">Composite score</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> LPIR</td>
                        <td rowspan="1" colspan="1">–5.3 (–9.2, –1.5)</td>
                        <td rowspan="1" colspan="1">–0.02 (–4.1, 4.1)</td>
                        <td rowspan="1" colspan="1">3.6 (–0.6, 7.7)</td>
                        <td rowspan="1" colspan="1">0.009</td>
                        <td rowspan="1" colspan="1">–8.9 (–14.6, –3.2)</td>
                        <td rowspan="1" colspan="1">0.002</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Particle sizes</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> TRL-P, nm</td>
                        <td rowspan="1" colspan="1">0.15 (–1.63, 1.92)</td>
                        <td rowspan="1" colspan="1">1.52 (–0.35, 3.39)</td>
                        <td rowspan="1" colspan="1">2.63 (0.72, 4.54)</td>
                        <td rowspan="1" colspan="1">0.17</td>
                        <td rowspan="1" colspan="1">–2.49 (–5.09, 0.12)</td>
                        <td rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> HDL-P, nm</td>
                        <td rowspan="1" colspan="1">0.09 (0.03, 0.15)</td>
                        <td rowspan="1" colspan="1">0.03 (–0.03, 0.10)</td>
                        <td rowspan="1" colspan="1">0.05 (–0.02, 0.11)</td>
                        <td rowspan="1" colspan="1">0.34</td>
                        <td rowspan="1" colspan="1">0.05 (–0.04, 0.13)</td>
                        <td rowspan="1" colspan="1">0.29</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> LDL-P, nm</td>
                        <td rowspan="1" colspan="1">0.06 (–0.05, 0.18)</td>
                        <td rowspan="1" colspan="1">0.16 (0.04, 0.28)</td>
                        <td rowspan="1" colspan="1">–0.01 (–0.14, 0.11)</td>
                        <td rowspan="1" colspan="1">0.14</td>
                        <td rowspan="1" colspan="1">0.08 (–0.09, 0.25)</td>
                        <td rowspan="1" colspan="1">0.38</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Particle concentrations</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Large/very large TRL-P,<sup><xref rid="tb2fn4" ref-type="table-fn">4</xref></sup> %</td>
                        <td rowspan="1" colspan="1">–9.5 (–24.0, 7.7)</td>
                        <td rowspan="1" colspan="1">10.9 (–7.6, 33.2)</td>
                        <td rowspan="1" colspan="1">38.5 (14.9, 67.0)</td>
                        <td rowspan="1" colspan="1">0.01</td>
                        <td rowspan="1" colspan="1">–34.7 (–49.4, –15.6)</td>
                        <td rowspan="1" colspan="1">0.001</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Large HDL-P, μmol/L</td>
                        <td rowspan="1" colspan="1">0.71 (0.48, 0.95)</td>
                        <td rowspan="1" colspan="1">0.36 (0.11, 0.60)</td>
                        <td rowspan="1" colspan="1">0.32 (0.07, 0.58)</td>
                        <td rowspan="1" colspan="1">0.045</td>
                        <td rowspan="1" colspan="1">0.39 (0.04, 0.73)</td>
                        <td rowspan="1" colspan="1">0.03</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Small LDL-P, μmol/L</td>
                        <td rowspan="1" colspan="1">–193.9 (–289.2, –98.0)</td>
                        <td rowspan="1" colspan="1">–221.7 (–322.5, –120.9)</td>
                        <td rowspan="1" colspan="1">–107.5 (–210.4, –4.5)</td>
                        <td rowspan="1" colspan="1">0.27</td>
                        <td rowspan="1" colspan="1">–86.4 (–227.2, 54.3)</td>
                        <td rowspan="1" colspan="1">0.23</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Large LDL-P, μmol/L</td>
                        <td rowspan="1" colspan="1">55.3 (9.3, 101.3)</td>
                        <td rowspan="1" colspan="1">54.6 (6.4, 102.9)</td>
                        <td rowspan="1" colspan="1">–1.1 (–50.4, 48.2)</td>
                        <td rowspan="1" colspan="1">0.18</td>
                        <td rowspan="1" colspan="1">56.4 (–11.0, 123.8)</td>
                        <td rowspan="1" colspan="1">0.10</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Lipoprotein(a),<sup><xref rid="tb2fn4" ref-type="table-fn">4</xref>,<xref rid="tb2fn5" ref-type="table-fn">5</xref></sup> %</td>
                        <td rowspan="1" colspan="1">–14.7 (–19.6, –9.5)</td>
                        <td rowspan="1" colspan="1">–2.1 (–8.2, 4.3)</td>
                        <td rowspan="1" colspan="1">0.2 (–6.0, 6.8)</td>
                        <td rowspan="1" colspan="1">0.0005</td>
                        <td rowspan="1" colspan="1">–14.9 (–22.0, –7.1)</td>
                        <td rowspan="1" colspan="1">0.0004</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Blood lipids</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Triglycerides,<sup><xref rid="tb2fn4" ref-type="table-fn">4</xref></sup> %</td>
                        <td rowspan="1" colspan="1">–9.2 (–15.6, –2.4)</td>
                        <td rowspan="1" colspan="1">1.9 (–5.6, 10.0)</td>
                        <td rowspan="1" colspan="1">7.6 (–0.5, 16.3)</td>
                        <td rowspan="1" colspan="1">0.006</td>
                        <td rowspan="1" colspan="1">–15.7 (–24.2, –6.2)</td>
                        <td rowspan="1" colspan="1">0.002</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Total cholesterol, mg/dL</td>
                        <td rowspan="1" colspan="1">16.1 (11.5, 20.7)</td>
                        <td rowspan="1" colspan="1">18.5 (13.6, 23.3)</td>
                        <td rowspan="1" colspan="1">16.2 (11.2, 21.1)</td>
                        <td rowspan="1" colspan="1">0.73</td>
                        <td rowspan="1" colspan="1">–0.1 (–6.8, 6.7)</td>
                        <td rowspan="1" colspan="1">0.99</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> HDL-C, mg/dL</td>
                        <td rowspan="1" colspan="1">9.8 (8.0, 11.5)</td>
                        <td rowspan="1" colspan="1">7.4 (5.6, 9.3)</td>
                        <td rowspan="1" colspan="1">6.7 (4.8, 8.5)</td>
                        <td rowspan="1" colspan="1">0.04</td>
                        <td rowspan="1" colspan="1">3.1 (0.5, 5.7)</td>
                        <td rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Non-HDL-C, mg/dL</td>
                        <td rowspan="1" colspan="1">6.3 (1.8, 10.9)</td>
                        <td rowspan="1" colspan="1">11.0 (6.3, 15.8)</td>
                        <td rowspan="1" colspan="1">9.5 (4.6, 14.4)</td>
                        <td rowspan="1" colspan="1">0.35</td>
                        <td rowspan="1" colspan="1">–3.2 (–9.8, 3.5)</td>
                        <td rowspan="1" colspan="1">0.35</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> LDL-C, mg/dL</td>
                        <td rowspan="1" colspan="1">10.0 (6.3, 13.7)</td>
                        <td rowspan="1" colspan="1">11.7 (7.8, 15.7)</td>
                        <td rowspan="1" colspan="1">8.2 (4.2, 12.2)</td>
                        <td rowspan="1" colspan="1">0.47</td>
                        <td rowspan="1" colspan="1">1.8 (–3.7, 7.3)</td>
                        <td rowspan="1" colspan="1">0.52</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Adiponectin</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Total,<sup><xref rid="tb2fn4" ref-type="table-fn">4</xref></sup> %</td>
                        <td rowspan="1" colspan="1">33.6 (24.9, 42.9)</td>
                        <td rowspan="1" colspan="1">17.4 (9.4, 26.0)</td>
                        <td rowspan="1" colspan="1">23.0 (14.5, 32.3)</td>
                        <td rowspan="1" colspan="1">0.03</td>
                        <td rowspan="1" colspan="1">8.6 (–1.6, 19.9)</td>
                        <td rowspan="1" colspan="1">0.10</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> High molecular weight,<sup><xref rid="tb2fn4" ref-type="table-fn">4</xref></sup> %</td>
                        <td rowspan="1" colspan="1">42.9 (33.3, 53.1)</td>
                        <td rowspan="1" colspan="1">27.6 (18.6, 37.2)</td>
                        <td rowspan="1" colspan="1">27.8 (18.7, 37.7)</td>
                        <td rowspan="1" colspan="1">0.04</td>
                        <td rowspan="1" colspan="1">11.8 (1.0, 23.7)</td>
                        <td rowspan="1" colspan="1">0.03</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Inflammatory mediators</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> hsCRP,<sup><xref rid="tb2fn4" ref-type="table-fn">4</xref>,<xref rid="tb2fn6" ref-type="table-fn">6</xref></sup> %</td>
                        <td rowspan="1" colspan="1">–9.9 (–24.2, 7.1)</td>
                        <td rowspan="1" colspan="1">–20.6 (–33.8, –4.8)</td>
                        <td rowspan="1" colspan="1">–1.7 (–18.6, 18.6)</td>
                        <td rowspan="1" colspan="1">0.27</td>
                        <td rowspan="1" colspan="1">–8.4 (–29.0, 18.3)</td>
                        <td rowspan="1" colspan="1">0.50</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> IL-6,<sup><xref rid="tb2fn4" ref-type="table-fn">4</xref></sup> %</td>
                        <td rowspan="1" colspan="1">–23.6 (–35.4, –9.6)</td>
                        <td rowspan="1" colspan="1">–20.1 (–33.0, –4.7)</td>
                        <td rowspan="1" colspan="1">–18.3 (–31.8, –2.2)</td>
                        <td rowspan="1" colspan="1">0.86</td>
                        <td rowspan="1" colspan="1">–6.5 (–26.9, 19.7)</td>
                        <td rowspan="1" colspan="1">0.59</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Blood pressure, mmHg</td>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                        <td rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Systolic<sup><xref rid="tb2fn7" ref-type="table-fn">7</xref></sup></td>
                        <td rowspan="1" colspan="1">–1.5 (–4.4, 1.5)</td>
                        <td rowspan="1" colspan="1">0.0 (–3.1, 3.1)</td>
                        <td rowspan="1" colspan="1">1.8 (–1.3, 5.0)</td>
                        <td rowspan="1" colspan="1">0.33</td>
                        <td rowspan="1" colspan="1">–3.3 (–7.7, 1.0)</td>
                        <td rowspan="1" colspan="1">0.13</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"> Diastolic<sup><xref rid="tb2fn7" ref-type="table-fn">7</xref></sup></td>
                        <td rowspan="1" colspan="1">2.2 (–0.4, 4.8)</td>
                        <td rowspan="1" colspan="1">1.4 (–1.3, 4.1)</td>
                        <td rowspan="1" colspan="1">2.2 (–0.6, 5.0)</td>
                        <td rowspan="1" colspan="1">0.89</td>
                        <td rowspan="1" colspan="1">0.03 (–3.8, 3.8)</td>
                        <td rowspan="1" colspan="1">0.99</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tb2fn1">
                      <label>1</label>
                      <p>Means (95% CI) were constructed and compared using unadjusted repeated measures
ANOVA. HDL-C, HDL cholesterol; HDL-P, high-density lipoprotein particle; hsCRP,
high-sensitivity C-reactive protein; LDL-C, LDL cholesterol; LPIR, lipoprotein
insulin resistance; LDL-P, low-density lipoprotein particle; TRL-P,
triglyceride-rich lipoprotein particle.</p>
                    </fn>
                    <fn id="tb2fn2">
                      <label>2</label>
                      <p>A partial <italic toggle="yes">F</italic> test was used to assess overall significance of diet
in the repeated measures model.</p>
                    </fn>
                    <fn id="tb2fn3">
                      <label>3</label>
                      <p>Pairwise comparison between Low-Carb and High-Carb was equivalent to a test for
linear trend across the 3 diets, recognizing equal increments in carbohydrate
content across the 3 diets.</p>
                    </fn>
                    <fn id="tb2fn4">
                      <label>4</label>
                      <p>Skewed variables were log- or log-plus-one–transformed for analysis. For reporting,
the least squares mean and 95% CIs from the model were retransformed to the original
units as (exp(log estimate)) for log transformations or (exp(log estimate) − 1) for
log-plus-one transformations. Changes are expressed in percentage units [100% ×
(exp(change in log) − 1)].</p>
                    </fn>
                    <fn id="tb2fn5">
                      <label>5</label>
                      <p>Because data were missing for 2 participants in Moderate-Carb, the lipoprotein(a)
analyses included <italic toggle="yes">n</italic> = 46 for this group. Values were below the
assay detection limit of 6.0 mg/dL for <italic toggle="yes">n</italic> = 38 at START (17 in
Low-Carb, 7 in Moderate-Carb, 14 in High-Carb) and <italic toggle="yes">n</italic> = 45 at END
(22 in Low-Carb, 10 in Moderate-Carb, 13 in High-Carb). We assigned values of
5.9 mg/dL. Consistent results were obtained when these data points were removed in a
sensitivity analysis.</p>
                    </fn>
                    <fn id="tb2fn6">
                      <label>6</label>
                      <p>Four influential data points (1 in Low-Carb, 1 in Moderate-Carb, 2 in High-Carb)
were not included in the analysis of hsCRP.</p>
                    </fn>
                    <fn id="tb2fn7">
                      <label>7</label>
                      <p>Blood pressure data were missing for 2 participants (1 in Low-Carb, 1 in
High-Carb).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>At PRE, LPIR had strong correlations with its 6 constituent components, and strong to
moderate correlations with other lipid variables related to insulin resistance
(<bold><xref rid="sup1" ref-type="supplementary-material">Supplemental Table
6</xref></bold>). Change in LPIR differed by diet group (<italic toggle="yes">P</italic> = 0.009),
with a decrease in Low-Carb (–5.3; 95% CI: –9.2, –1.5; <italic toggle="yes">P</italic> = 0.007), no
change in Moderate-Carb (–0.02; 95% CI: –4.1, 4.1; <italic toggle="yes">P</italic> = 0.99), and a
nonsignificant increase in High-Carb (3.6; 95% CI: –0.6, 7.7; <italic toggle="yes">P</italic> = 0.09).
The components of the score that contributed most notably to the difference between
Low-Carb and High-Carb were sum of large and very large TRL-P (lower for Low-Carb,
<italic toggle="yes">P</italic> = 0.001) and large HDL-P (higher for Low-Carb,
<italic toggle="yes">P</italic> = 0.03) concentrations. Other components of the score (TRL-P, HDL-P,
and LDL-P sizes; small LDL-P concentration) and large LDL-P concentration did not differ
individually by diet group.</p>
                <p>Percentage change in Lp(a) differed by diet group (<italic toggle="yes">P</italic> = 0.0005), with a
decrease in Low-Carb (–14.7; 95% CI: –19.6, –9.5; <italic toggle="yes">P</italic> &lt; 0.0001) and no
change in Moderate-Carb (–2.1; 95% CI: –8.2, 4.3; <italic toggle="yes">P</italic> = 0.51) and High-Carb
(0.2; 95% CI: –6.0, 6.8; <italic toggle="yes">P</italic> = 0.96). Changes in triglycerides
(<italic toggle="yes">P</italic> = 0.002) and HDL cholesterol (<italic toggle="yes">P</italic> = 0.02) favored
Low-Carb compared with High-Carb. LDL cholesterol increased in all groups—potentially
reflecting adaptation to increased energy intake in the Test phase—without difference by
group. Changes in adiponectin (total, <italic toggle="yes">P</italic> = 0.03; HMW,
<italic toggle="yes">P</italic> = 0.04) differed by diet group, and the pairwise comparison for HMW
adiponectin favored Low-Carb (<xref rid="tbl2" ref-type="table">Table 2</xref>). Measures
of chronic inflammation (hsCRP, IL-6) and blood pressure did not differ by group.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4">
              <title>Discussion</title>
              <p>Carbohydrate restriction shows promise for the treatment of diabetes and other prevalent
chronic diet-related diseases (<xref rid="bib22" ref-type="bibr">22</xref>). However,
low-carbohydrate diets are characteristically high in saturated fat, raising concern for
adverse effects. In the United States and Europe, saturated fat intake is strongly
associated with LDL cholesterol and with cardiovascular morbidity and total mortality (<xref rid="bib3" ref-type="bibr">3</xref>). Nevertheless, these observational findings derive
from populations with relatively high intakes of carbohydrate. For example, in a 2-cohort
study of mortality beginning in the 1980s, mean dietary carbohydrate as a proportion of
energy intake ranged from 54% for women and 56% for men in the lowest quintile of saturated
fat consumption, to 35% for women and 41% for men in the highest quintile (<xref rid="bib23" ref-type="bibr">23</xref>). For this reason, experimental evidence is needed
regarding how low-carbohydrate diets with high saturated fat content affect CVD risk
factors.</p>
              <p>In this feeding trial, we found that carbohydrate restriction had dose-dependent benefits
for insulin-resistant dyslipoproteinemia, without adverse effects on total cholesterol, LDL
cholesterol, LDL-P size, measures of chronic inflammation, or blood pressure. The
low-carbohydrate diet also increased adiponectin, an adipocyte hormone that promotes insulin
sensitivity and protects against atherogenesis (<xref rid="bib24" ref-type="bibr">24</xref>). In addition, we found a potentially novel dietary effect on Lp(a), a major
independent and causal risk factor for atherosclerosis (<xref rid="bib25" ref-type="bibr">25</xref>). A recent review of trials ranging from 3 to 8 wk reported that “diet modestly
affects Lp(a) and often in the opposing direction to LDL-C” (<xref rid="bib26" ref-type="bibr">26</xref>), consistent with findings from the Delta Study in 1998 (<xref rid="bib27" ref-type="bibr">27</xref>). Nevertheless, the prevailing view, as exemplified
by a Scientific Statement from the National Lipid Association, holds that “Lifestyle
therapy, including diet and physical exercise, has no significant effect on Lp(a)
concentrations,” motivating the search for new pharmacological options (<xref rid="bib25" ref-type="bibr">25</xref>). Lacking recognized treatment options, this
important risk factor might not be consistently monitored in the clinical setting.</p>
              <p>These findings suggests that a dietary strategy focused on carbohydrate restriction might
not raise, and could potentially lower, CVD risk. To the extent that a low-carbohydrate diet
results in greater weight loss, overall magnitude of CVD risk reduction could be greater
than suggested here. These results are broadly consistent with small feeding trials and
behavioral studies that report improvements in multiple cardiometabolic outcomes on
low-carbohydrate diets, including triglycerides, HDL cholesterol, glycemia, blood pressure,
liver fat, and body weight (<xref rid="bib28" ref-type="bibr">28–31</xref>). Effects on these risk factors could mediate, to some degree, the
associations between glycemic load and risk of CVD events and mortality observed in a recent
20-country study (<xref rid="bib32" ref-type="bibr">32</xref>).</p>
              <p>In contrast to our findings, some (<xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref>) but not all (<xref rid="bib35" ref-type="bibr">35</xref>) meta-analyses of clinical trials report higher LDL cholesterol on
low-carbohydrate diets—heterogeneity that could relate to dietary composition, participant
characteristics, study duration, or other design issues. In the DIETFITS trial (<xref rid="bib36" ref-type="bibr">36</xref>), involving 609 participants assigned to a “healthy
low-carbohydrate” or “healthy low-fat” diet (both with an emphasis on reducing intake of
processed carbohydrates), LDL cholesterol increased by 5.7 mg/dL in the low-carbohydrate
group over 12 mo. Interestingly, the association between change in saturated fat intake and
LDL cholesterol was significant in the low-fat but not the low-carbohydrate group. Even so,
cases of severe LDL cholesterol elevation have been reported on low-carbohydrate diets
(<xref rid="bib37" ref-type="bibr">37</xref>), characteristically involving individuals
with genetic predisposition, those who consumed a more restrictive diet than was used in our
study, or those who had recently experienced rapid weight loss (a cause of transient
hypercholesterolemia (<xref rid="bib38" ref-type="bibr">38</xref>).</p>
              <p>Excluding these extreme examples, other effects of a low-carbohydrate diet might attenuate
or counterbalance any risk associated with the moderate LDL cholesterol elevation that can
occur in some individuals. Even at higher LDL cholesterol concentrations, lipid markers of
insulin sensitivity, such as low triglycerides and high HDL cholesterol, are associated with
relatively low CVD risk (<xref rid="bib39" ref-type="bibr">39–41</xref>). In a
prospective cohort study, insulin-resistant dyslipoproteinemia compared with LDL cholesterol
was a stronger biomarker risk factor for early-onset coronary heart disease in women (<xref rid="bib13" ref-type="bibr">13</xref>). According to a modeling study, insulin resistance
compared with LDL cholesterol could account for a greater proportion of coronary artery
disease risk in adults aged 20–30 y (<xref rid="bib42" ref-type="bibr">42</xref>)
(reflecting a range included in our trial). Moreover, in the pharmacological management of
risk factors, drugs for elevated LDL cholesterol (were it to occur on a low-carbohydrate
diet) are generally more effective and better tolerated than drugs for metabolic syndrome
components (were they to occur on a high-carbohydrate diet). A Mediterranean-style
low-carbohydrate diet, with an emphasis on unsaturated fats, provides a nonpharmacological
option to target both insulin-resistant dyslipoproteinemia and elevated LDL cholesterol
(<xref rid="bib43" ref-type="bibr">43</xref>).</p>
              <p>Our study could also have special public health relevance during the Coronavirus Disease
2019 (COVID-19) pandemic. Obesity is among the most important risk factors for disease
susceptibility and severity (<xref rid="bib44" ref-type="bibr">44–46</xref>),
perhaps second only to advanced age. Insulin resistance might mediate this relation, in
part, through effects on numerous metabolic, immunological, and inflammatory pathways (<xref rid="bib47" ref-type="bibr">47</xref>, <xref rid="bib48" ref-type="bibr">48</xref>). Thus,
carbohydrate restriction could play an ancillary role, in addition to vaccination, in
promoting metabolic health and resistance to COVID-19 morbidity and mortality.</p>
              <p>Strengths of this trial include use of a feeding protocol to enhance dietary adherence and
differentiation between groups; inclusion of diets differing substantially in carbohydrate,
but without extreme restriction of any macronutrient, potentially enhancing clinical
practicality; high participant retention rate, reducing bias from missing data; large sample
size for a feeding study, providing comparatively strong power; long duration, exceeding the
time thought necessary to reach a steady state for LDL cholesterol following weight loss
(<xref rid="bib38" ref-type="bibr">38</xref>); and control for dietary protein and body
weight. Another notable design feature was a run-in phase designed to achieve a clinically
relevant, but not unrealistic, amount of weight loss, considering that weight reduction is
the first-line approach for CVD risk reduction in individuals with overweight or
obesity.</p>
              <p>The main limitation is generalizability. Our cohort comprised young to middle-aged,
relatively healthy adults with low LDL cholesterol. We do not know how our findings would
apply to other populations, especially older, higher-risk groups, or individuals consuming
more restrictive diets (e.g., a ketogenic diet, with carbohydrate &lt;10% of total energy).
Furthermore, even within the macronutrient targets in our study, diets can differ in myriad
ways, such as the ratio of saturated to unsaturated fatty acids, amounts of MUFAs and PUFAs,
fiber type and amount, food processing, glycemic index, and micronutrient content.
Therefore, the effects observed here might not occur on all diets with similar
macronutrients. However, we aimed to employ healthful, palatable, and pragmatic
representations of each diet type, with relevance to clinical translation. Another
limitation is risk of false discovery. However, for the key findings involving LPIR and
Lp(a), the low- compared with high-carbohydrate diet comparisons would remain statistically
significant after conservative Bonferroni adjustment for all 20 outcomes considered in this
study. Outcomes with less robust <italic toggle="yes">P</italic> values (notably adiponectin, HDL
cholesterol, and large HDL-P) should be interpreted cautiously, although consistent data
from prior studies can enhance confidence in the findings for HDL cholesterol and HDL-P
(<xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>,
<xref rid="bib33" ref-type="bibr">33</xref>). In contrast, the informative negative
outcomes involving LDL cholesterol and LDL-P are clearly nonsignificant, although we lack
power to rule out a small diet effect.</p>
              <p>In conclusion, we found that carbohydrate restriction had benefits for insulin-resistant
dyslipoproteinemia and Lp(a), without adverse effects on LDL cholesterol or inflammation.
This finding, together with preliminary data on body weight, glycemia, and other
cardiometabolic risk factors, suggests that low-carbohydrate diets can have novel benefits
for preventing both diabetes and CVD in an era with highly prevalent obesity and insulin
resistance. Multicentered trials powered for hard outcomes, comparable to the Women's Health
Initiative clinical trial and Look Ahead Study, which utilized low-fat diets, are needed to
test this possibility.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material id="sup1" position="float" content-type="local-data">
                <label>nqab287_Supplemental_File</label>
                <media xlink:href="nqab287_supplemental_file.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="ack1">
              <title>Acknowledgments</title>
              <p>We thank the study participants for their time and commitment to advancing science. We also
acknowledge Gloria Klein (Study Director, oversight of study operations), Patricia Luoto
(Study Director, Framingham State University), Lisa Bielak (Nutrition Research Manager,
implementation of dietary intervention), and Shui Yu (Biostatistician, replication of data
analysis).</p>
              <p>The authors’ responsibilities were as follows—CBE, DSL: principal investigators of the
parent trial and participated in all aspects of design, conduct, and manuscript preparation
for the current study; AK, AJ: participated in design and data acquisition, and revised the
manuscript; JMWW: participated in conduct of the parent trial and revised the manuscript;
KFG, CM: conducted the statistical analyses and revised the manuscript; SM: helped design
the study and interpret the data and revised the manuscript; and all authors: read and
approved the final manuscript. SM has served as a consultant to Pfizer and Quest Diagnostics
for work unrelated to the current study, and has a patent regarding the use of GlycA, an
NMR-measured biomarker, in relation to colorectal cancer risk. DSL reported receiving
royalties from books on nutrition and obesity that recommend a carbohydrate-modified diet;
and his spouse owns a nutrition education and consulting business. All other authors report
no conflicts of interest.</p>
            </ack>
            <sec sec-type="data-availability" id="sec5">
              <title>Data Availability</title>
              <p>The full trial protocol and the database are publicly available on Open Science Framework
(<ext-link xlink:href="https://osf.io/rvbuy/" ext-link-type="uri">https://osf.io/rvbuy/</ext-link>).</p>
            </sec>
            <notes id="nt1">
              <title>Notes</title>
              <p>This work was supported by grants from Nutrition Science Initiative (made possible by gifts
from Arnold Ventures and Robert Lloyd Corkin Charitable Foundation), New Balance Foundation,
Many Voices Foundation, and Blue Cross Blue Shield. DSL was supported by a mid-career
mentoring award from the National Institute of Diabetes and Digestive and Kidney Diseases
(K24DK082730). SM was supported by the National Heart, Lung, and Blood Institute
(K24HL136852). Nutrition Science Initiative monitored study progress and was given an
opportunity to comment on the manuscript. The funders had no role in the design and conduct
of the study; collection, management, analysis, and interpretation of the data; approval of
the manuscript; and decision to submit the manuscript for publication. The content of this
article is solely the responsibility of the authors and does not necessarily represent the
official views of the study sponsors.</p>
              <p>DSL is an Associate Editor of <italic toggle="yes">The American Journal of Clinical Nutrition</italic>
and was not involved in the editorial evaluation of this manuscript.</p>
              <p>Supplemental Methods, Supplemental Material, Supplemental Tables 1–6, and Supplemental
Figure 1 are available from the “Supplementary data” link in the online posting of the
article and from the same link in the online table of contents at <ext-link xlink:href="https://academic.oup.com/ajcn/" ext-link-type="uri">https://academic.oup.com/ajcn/</ext-link>.</p>
              <p>Abbreviations used: Carb, carbohydrate; CVD, cardiovascular disease; HDL-P, high-density
lipoprotein particle; HMW, high molecular weight; hsCRP, high-sensitivity C-reactive
protein; LPIR, lipoprotein insulin resistance; Lp(a), lipoprotein(a); LDL-P, low-density
lipoprotein particle; TRL-P, triglyceride-rich lipoprotein particle.</p>
            </notes>
            <ref-list id="ref1">
              <title>References</title>
              <ref id="bib1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jahns</surname><given-names>L</given-names></string-name>, <string-name><surname>Davis-Shaw</surname><given-names>W</given-names></string-name>,
<string-name><surname>Lichtenstein</surname><given-names>AH</given-names></string-name>,
<string-name><surname>Murphy</surname><given-names>SP</given-names></string-name>, <string-name><surname>Conrad</surname><given-names>Z</given-names></string-name>, <string-name><surname>Nielsen</surname><given-names>F</given-names></string-name></person-group>.
<article-title>The history and future of dietary guidance in America</article-title>.
<source>Adv Nutr</source>.
<year>2018</year>;<volume>9</volume>(<issue>2</issue>):<fpage>136</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">29659693</pub-id></mixed-citation>
              </ref>
              <ref id="bib2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kris-Etherton</surname><given-names>PM</given-names></string-name>, <string-name><surname>Krauss</surname><given-names>RM</given-names></string-name></person-group>.
<article-title>Public health guidelines should recommend reducing saturated fat
consumption as much as possible: YES</article-title>. <source>Am J Clin Nutr</source>.
<year>2020</year>;<volume>112</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">32491173</pub-id></mixed-citation>
              </ref>
              <ref id="bib3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Lichtenstein</surname><given-names>AH</given-names></string-name>,
<string-name><surname>Wu</surname><given-names>JHY</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Creager</surname><given-names>MA</given-names></string-name>, <string-name><surname>Kris-Etherton</surname><given-names>PM</given-names></string-name>,
<string-name><surname>Miller</surname><given-names>M</given-names></string-name>, <string-name><surname>Rimm</surname><given-names>EB</given-names></string-name>, <string-name><surname>Rudel</surname><given-names>LL</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>JG</given-names></string-name><etal>et
al.</etal></person-group><article-title>Dietary fats and cardiovascular disease: a Presidential Advisory from the
American Heart Association</article-title>. <source>Circulation</source>.
<year>2017</year>;<volume>136</volume>(<issue>3</issue>):<fpage>e1</fpage>–<lpage>e23</lpage>.<pub-id pub-id-type="pmid">28620111</pub-id></mixed-citation>
              </ref>
              <ref id="bib4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jakobsen</surname><given-names>MU</given-names></string-name>, <string-name><surname>Dethlefsen</surname><given-names>C</given-names></string-name>,
<string-name><surname>Joensen</surname><given-names>AM</given-names></string-name>, <string-name><surname>Stegger</surname><given-names>J</given-names></string-name>, <string-name><surname>Tjonneland</surname><given-names>A</given-names></string-name>, <string-name><surname>Schmidt</surname><given-names>EB</given-names></string-name>, <string-name><surname>Overvad</surname><given-names>K</given-names></string-name></person-group>.
<article-title>Intake of carbohydrates compared with intake of saturated fatty acids and
risk of myocardial infarction: importance of the glycemic index</article-title>.
<source>Am J Clin Nutr</source>.
<year>2010</year>;<volume>91</volume>(<issue>6</issue>):<fpage>1764</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">20375186</pub-id></mixed-citation>
              </ref>
              <ref id="bib5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reaven</surname><given-names>GM</given-names></string-name></person-group>. <article-title>Do high carbohydrate diets prevent the development or
attenuate the manifestations (or both) of syndrome X? A viewpoint strongly
against</article-title>. <source>Curr Opin Lipidol</source>.
<year>1997</year>;<volume>8</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">9127707</pub-id></mixed-citation>
              </ref>
              <ref id="bib6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siri-Tarino</surname><given-names>PW</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Q</given-names></string-name>, <string-name><surname>Hu</surname><given-names>FB</given-names></string-name>,
<string-name><surname>Krauss</surname><given-names>RM</given-names></string-name></person-group>.
<article-title>Saturated fat, carbohydrate, and cardiovascular disease</article-title>.
<source>Am J Clin Nutr</source>.
<year>2010</year>;<volume>91</volume>(<issue>3</issue>):<fpage>502</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">20089734</pub-id></mixed-citation>
              </ref>
              <ref id="bib7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Evert</surname><given-names>AB</given-names></string-name>, <string-name><surname>Dennison</surname><given-names>M</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>CD</given-names></string-name>, <string-name><surname>Garvey</surname><given-names>WT</given-names></string-name>, <string-name><surname>Lau</surname><given-names>KHK</given-names></string-name>, <string-name><surname>MacLeod</surname><given-names>J</given-names></string-name>, <string-name><surname>Mitri</surname><given-names>J</given-names></string-name>, <string-name><surname>Pereira</surname><given-names>RF</given-names></string-name>, <string-name><surname>Rawlings</surname><given-names>K</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>S</given-names></string-name><etal>et
al.</etal></person-group><article-title>Nutrition therapy for adults with diabetes or prediabetes: a consensus
report</article-title>. <source>Diabetes Care</source>.
<year>2019</year>;<volume>42</volume>(<issue>5</issue>):<fpage>731</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">31000505</pub-id></mixed-citation>
              </ref>
              <ref id="bib8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Athinarayanan</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Adams</surname><given-names>RN</given-names></string-name>, <string-name><surname>Hallberg</surname><given-names>SJ</given-names></string-name>, <string-name><surname>McKenzie</surname><given-names>AL</given-names></string-name>, <string-name><surname>Bhanpuri</surname><given-names>NH</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>WW</given-names></string-name>, <string-name><surname>Volek</surname><given-names>JS</given-names></string-name>, <string-name><surname>Phinney</surname><given-names>SD</given-names></string-name>, <string-name><surname>McCarter</surname><given-names>JP</given-names></string-name></person-group>.
<article-title>Long-term effects of a novel continuous remote care intervention
including nutritional ketosis for the management of type 2 diabetes: a 2-year
non-randomized clinical trial</article-title>. <source>Front Endocrinol</source>.
<year>2019</year>;<volume>10</volume>:<fpage>348</fpage>.</mixed-citation>
              </ref>
              <ref id="bib9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saslow</surname><given-names>LR</given-names></string-name>, <string-name><surname>Daubenmier</surname><given-names>JJ</given-names></string-name>,
<string-name><surname>Moskowitz</surname><given-names>JT</given-names></string-name>,
<string-name><surname>Kim</surname><given-names>S</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Phinney</surname><given-names>SD</given-names></string-name>, <string-name><surname>Ploutz-Snyder</surname><given-names>R</given-names></string-name>,
<string-name><surname>Goldman</surname><given-names>V</given-names></string-name>, <string-name><surname>Cox</surname><given-names>RM</given-names></string-name>, <string-name><surname>Mason</surname><given-names>AE</given-names></string-name><etal>et
al.</etal></person-group><article-title>Twelve-month outcomes of a randomized trial of a moderate-carbohydrate
versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or
prediabetes</article-title>. <source>Nutr Diabetes</source>.
<year>2017</year>;<volume>7</volume>(<issue>12</issue>):<fpage>304</fpage>.<pub-id pub-id-type="pmid">29269731</pub-id></mixed-citation>
              </ref>
              <ref id="bib10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harada</surname><given-names>PHN</given-names></string-name>, <string-name><surname>Demler</surname><given-names>OV</given-names></string-name>, <string-name><surname>Dugani</surname><given-names>SB</given-names></string-name>, <string-name><surname>Akinkuolie</surname><given-names>AO</given-names></string-name>,
<string-name><surname>Moorthy</surname><given-names>MV</given-names></string-name>, <string-name><surname>Ridker</surname><given-names>PM</given-names></string-name>, <string-name><surname>Cook</surname><given-names>NR</given-names></string-name>, <string-name><surname>Pradhan</surname><given-names>AD</given-names></string-name>, <string-name><surname>Mora</surname><given-names>S</given-names></string-name></person-group>.
<article-title>Lipoprotein insulin resistance score and risk of incident diabetes during
extended follow-up of 20 years: the Women's Health Study</article-title>. <source>J Clin
Lipidol</source>.
<year>2017</year>;<volume>11</volume>(<issue>5</issue>):<fpage>1257</fpage>–<lpage>67.e2</lpage>.<pub-id pub-id-type="pmid">28733174</pub-id></mixed-citation>
              </ref>
              <ref id="bib11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mozaffarian</surname><given-names>D</given-names></string-name></person-group>. <article-title>The great fat debate: taking the focus off of saturated
fat</article-title>. <source>J Am Diet Assoc</source>.
<year>2011</year>;<volume>111</volume>(<issue>5</issue>):<fpage>665</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">21515109</pub-id></mixed-citation>
              </ref>
              <ref id="bib12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dugani</surname><given-names>SB</given-names></string-name>, <string-name><surname>Akinkuolie</surname><given-names>AO</given-names></string-name>,
<string-name><surname>Paynter</surname><given-names>N</given-names></string-name>, <string-name><surname>Glynn</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Ridker</surname><given-names>PM</given-names></string-name>, <string-name><surname>Mora</surname><given-names>S</given-names></string-name></person-group>.
<article-title>Association of lipoproteins, insulin resistance, and rosuvastatin with
incident type 2 diabetes mellitus: secondary analysis of a randomized clinical
trial</article-title>. <source>JAMA Cardiol</source>.
<year>2016</year>;<volume>1</volume>(<issue>2</issue>):<fpage>136</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">27347563</pub-id></mixed-citation>
              </ref>
              <ref id="bib13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dugani</surname><given-names>SB</given-names></string-name>, <string-name><surname>Moorthy</surname><given-names>MV</given-names></string-name>, <string-name><surname>Li</surname><given-names>C</given-names></string-name>,
<string-name><surname>Demler</surname><given-names>OV</given-names></string-name>, <string-name><surname>Alsheikh-Ali</surname><given-names>AA</given-names></string-name>,
<string-name><surname>Ridker</surname><given-names>PM</given-names></string-name>, <string-name><surname>Glynn</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Mora</surname><given-names>S</given-names></string-name></person-group>.
<article-title>Association of lipid, inflammatory, and metabolic biomarkers with age at
onset for incident coronary heart disease in women</article-title>. <source>JAMA
Cardiol</source>.
<year>2021</year>;<volume>6</volume>(<issue>4</issue>):<fpage>437</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">33471027</pub-id></mixed-citation>
              </ref>
              <ref id="bib14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pagidipati</surname><given-names>NJ</given-names></string-name>, <string-name><surname>Pencina</surname><given-names>M</given-names></string-name>, <string-name><surname>Sniderman</surname><given-names>AD</given-names></string-name></person-group>.
<article-title>The enigma of glucose and lipid metabolism</article-title>. <source>JAMA
Cardiol</source>.
<year>2016</year>;<volume>1</volume>(<issue>2</issue>):<fpage>145</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">27437884</pub-id></mixed-citation>
              </ref>
              <ref id="bib15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shalaurova</surname><given-names>I</given-names></string-name>, <string-name><surname>Connelly</surname><given-names>MA</given-names></string-name>,
<string-name><surname>Garvey</surname><given-names>WT</given-names></string-name>, <string-name><surname>Otvos</surname><given-names>JD</given-names></string-name></person-group>.
<article-title>Lipoprotein insulin resistance index: a lipoprotein particle-derived
measure of insulin resistance</article-title>. <source>Metab Syndr Relat
Disord</source>.
<year>2014</year>;<volume>12</volume>(<issue>8</issue>):<fpage>422</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">24959989</pub-id></mixed-citation>
              </ref>
              <ref id="bib16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ebbeling</surname><given-names>CB</given-names></string-name>, <string-name><surname>Klein</surname><given-names>GL</given-names></string-name>, <string-name><surname>Luoto</surname><given-names>PK</given-names></string-name>, <string-name><surname>Wong</surname><given-names>JMW</given-names></string-name>, <string-name><surname>Bielak</surname><given-names>L</given-names></string-name>, <string-name><surname>Eddy</surname><given-names>RG</given-names></string-name>, <string-name><surname>Steltz</surname><given-names>SK</given-names></string-name>, <string-name><surname>Devlin</surname><given-names>C</given-names></string-name>, <string-name><surname>Sandman</surname><given-names>M</given-names></string-name>, <string-name><surname>Hron</surname><given-names>B</given-names></string-name><etal>et
al.</etal></person-group><article-title>A randomized study of dietary composition during weight-loss maintenance:
rationale, study design, intervention, and assessment</article-title>. <source>Contemp
Clin Trials</source>.
<year>2018</year>;<volume>65</volume>:<fpage>76</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">29233719</pub-id></mixed-citation>
              </ref>
              <ref id="bib17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wong</surname><given-names>JM</given-names></string-name>, <string-name><surname>Bielak</surname><given-names>L</given-names></string-name>, <string-name><surname>Eddy</surname><given-names>RG</given-names></string-name>, <string-name><surname>Stone</surname><given-names>L</given-names></string-name>, <string-name><surname>Lakin</surname><given-names>PR</given-names></string-name>, <string-name><surname>Sandman</surname><given-names>M</given-names></string-name>, <string-name><surname>Devlin</surname><given-names>C</given-names></string-name>, <string-name><surname>Seger-Shippee</surname><given-names>L</given-names></string-name>,
<string-name><surname>Wiroll</surname><given-names>D</given-names></string-name>, <string-name><surname>Luoto</surname><given-names>PK</given-names></string-name><etal>et
al.</etal></person-group><article-title>An academia-industry partnership for planning and executing a
community-based feeding study</article-title>. <source>Curr Dev Nutr</source>.
<year>2018</year>;<volume>2</volume>(<issue>9</issue>):<comment>nzy060</comment>.</mixed-citation>
              </ref>
              <ref id="bib18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ebbeling</surname><given-names>CB</given-names></string-name>, <string-name><surname>Feldman</surname><given-names>HA</given-names></string-name>, <string-name><surname>Klein</surname><given-names>GL</given-names></string-name>, <string-name><surname>Wong</surname><given-names>JMW</given-names></string-name>, <string-name><surname>Bielak</surname><given-names>L</given-names></string-name>, <string-name><surname>Steltz</surname><given-names>SK</given-names></string-name>, <string-name><surname>Luoto</surname><given-names>PK</given-names></string-name>, <string-name><surname>Wolfe</surname><given-names>RR</given-names></string-name>, <string-name><surname>Wong</surname><given-names>WW</given-names></string-name>, <string-name><surname>Ludwig</surname><given-names>DS</given-names></string-name></person-group>.
<article-title>Effects of a low carbohydrate diet on energy expenditure during weight
loss maintenance: randomized trial</article-title>. <source>BMJ</source>.
<year>2018</year>;<volume>363</volume>:<fpage>k4583</fpage>.<pub-id pub-id-type="pmid">30429127</pub-id></mixed-citation>
              </ref>
              <ref id="bib19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aday</surname><given-names>AW</given-names></string-name>, <string-name><surname>Lawler</surname><given-names>PR</given-names></string-name>, <string-name><surname>Cook</surname><given-names>NR</given-names></string-name>, <string-name><surname>Ridker</surname><given-names>PM</given-names></string-name>, <string-name><surname>Mora</surname><given-names>S</given-names></string-name>, <string-name><surname>Pradhan</surname><given-names>AD</given-names></string-name></person-group>.
<article-title>Lipoprotein particle profiles, standard lipids, and peripheral artery
disease incidence</article-title>. <source>Circulation</source>.
<year>2018</year>;<volume>138</volume>(<issue>21</issue>):<fpage>2330</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">30021845</pub-id></mixed-citation>
              </ref>
              <ref id="bib20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flores-Guerrero</surname><given-names>JL</given-names></string-name>, <string-name><surname>Connelly</surname><given-names>MA</given-names></string-name>,
<string-name><surname>Shalaurova</surname><given-names>I</given-names></string-name>,
<string-name><surname>Gruppen</surname><given-names>EG</given-names></string-name>, <string-name><surname>Kieneker</surname><given-names>LM</given-names></string-name>, <string-name><surname>Dullaart</surname><given-names>RPF</given-names></string-name>, <string-name><surname>Bakker</surname><given-names>SJL</given-names></string-name></person-group>.
<article-title>Lipoprotein insulin resistance index, a high-throughput measure of
insulin resistance, is associated with incident type II diabetes mellitus in the
Prevention of Renal and Vascular End-Stage Disease study</article-title>. <source>J Clin
Lipidol</source>.
<year>2019</year>;<volume>13</volume>(<issue>1</issue>):<fpage>129</fpage>–<lpage>37.e1</lpage>.<pub-id pub-id-type="pmid">30591414</pub-id></mixed-citation>
              </ref>
              <ref id="bib21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marcovina</surname><given-names>SM</given-names></string-name>, <string-name><surname>Albers</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Scanu</surname><given-names>AM</given-names></string-name>, <string-name><surname>Kennedy</surname><given-names>H</given-names></string-name>, <string-name><surname>Giaculli</surname><given-names>F</given-names></string-name>, <string-name><surname>Berg</surname><given-names>K</given-names></string-name>, <string-name><surname>Couderc</surname><given-names>R</given-names></string-name>, <string-name><surname>Dati</surname><given-names>F</given-names></string-name>, <string-name><surname>Rifai</surname><given-names>N</given-names></string-name>, <string-name><surname>Sakurabayashi</surname><given-names>I</given-names></string-name><etal>et
al.</etal></person-group><article-title>Use of a reference material proposed by the International Federation of
Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the
determination of plasma lipoprotein(a)</article-title>. <source>Clin Chem</source>.
<year>2000</year>;<volume>46</volume>(<issue>12</issue>):<fpage>1956</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">11106328</pub-id></mixed-citation>
              </ref>
              <ref id="bib22">
                <label>22.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ludwig</surname><given-names>DS</given-names></string-name></person-group>. <article-title>The ketogenic diet: evidence for optimism but high-quality
research needed</article-title>. <source>J Nutr</source>.
<year>2020</year>;<volume>150</volume>(<issue>6</issue>):<fpage>1354</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">31825066</pub-id></mixed-citation>
              </ref>
              <ref id="bib23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>DD</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chiuve</surname><given-names>SE</given-names></string-name>, <string-name><surname>Stampfer</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Rimm</surname><given-names>EB</given-names></string-name>, <string-name><surname>Willett</surname><given-names>WC</given-names></string-name>, <string-name><surname>Hu</surname><given-names>FB</given-names></string-name></person-group>.
<article-title>Association of specific dietary fats with total and cause-specific
mortality</article-title>. <source>JAMA Intern Med</source>.
<year>2016</year>;<volume>176</volume>(<issue>8</issue>):<fpage>1134</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">27379574</pub-id></mixed-citation>
              </ref>
              <ref id="bib24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yanai</surname><given-names>H</given-names></string-name>, <string-name><surname>Yoshida</surname><given-names>H</given-names></string-name></person-group>.
<article-title>Beneficial effects of adiponectin on glucose and lipid metabolism and
atherosclerotic progression: mechanisms and perspectives</article-title>. <source>Int J
Mol Sci</source>.
<year>2019</year>;<volume>20</volume>(<issue>5</issue>):<fpage>1190</fpage>.</mixed-citation>
              </ref>
              <ref id="bib25">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilson</surname><given-names>DP</given-names></string-name>, <string-name><surname>Jacobson</surname><given-names>TA</given-names></string-name>,
<string-name><surname>Jones</surname><given-names>PH</given-names></string-name>, <string-name><surname>Koschinsky</surname><given-names>ML</given-names></string-name>,
<string-name><surname>McNeal</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Nordestgaard</surname><given-names>BG</given-names></string-name>,
<string-name><surname>Orringer</surname><given-names>CE</given-names></string-name></person-group>.
<article-title>Use of lipoprotein(a) in clinical practice: a biomarker whose time has
come. A scientific statement from the National Lipid Association</article-title>.
<source>J Clin Lipidol</source>.
<year>2019</year>;<volume>13</volume>(<issue>3</issue>):<fpage>374</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">31147269</pub-id></mixed-citation>
              </ref>
              <ref id="bib26">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Enkhmaa</surname><given-names>B</given-names></string-name>, <string-name><surname>Petersen</surname><given-names>KS</given-names></string-name>,
<string-name><surname>Kris-Etherton</surname><given-names>PM</given-names></string-name>,
<string-name><surname>Berglund</surname><given-names>L</given-names></string-name></person-group>.
<article-title>Diet and Lp(a): does dietary change modify residual cardiovascular risk
conferred by Lp(a)?</article-title>. <source>Nutrients</source>.
<year>2020</year>;<volume>12</volume>(<issue>7</issue>):<fpage>2024</fpage>.</mixed-citation>
              </ref>
              <ref id="bib27">
                <label>27.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ginsberg</surname><given-names>HN</given-names></string-name>, <string-name><surname>Kris-Etherton</surname><given-names>P</given-names></string-name>,
<string-name><surname>Dennis</surname><given-names>B</given-names></string-name>, <string-name><surname>Elmer</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Ershow</surname><given-names>A</given-names></string-name>, <string-name><surname>Lefevre</surname><given-names>M</given-names></string-name>, <string-name><surname>Pearson</surname><given-names>T</given-names></string-name>, <string-name><surname>Roheim</surname><given-names>P</given-names></string-name>, <string-name><surname>Ramakrishnan</surname><given-names>R</given-names></string-name>,
<string-name><surname>Reed</surname><given-names>R</given-names></string-name><etal>et
al.</etal></person-group><article-title>Effects of reducing dietary saturated fatty acids on plasma lipids and
lipoproteins in healthy subjects: the DELTA Study, protocol 1</article-title>.
<source>Arterioscler Thromb Vasc Biol</source>.
<year>1998</year>;<volume>18</volume>(<issue>3</issue>):<fpage>441</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">9514413</pub-id></mixed-citation>
              </ref>
              <ref id="bib28">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dong</surname><given-names>T</given-names></string-name>, <string-name><surname>Guo</surname><given-names>M</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>P</given-names></string-name>, <string-name><surname>Sun</surname><given-names>G</given-names></string-name>,
<string-name><surname>Chen</surname><given-names>B</given-names></string-name></person-group>.
<article-title>The effects of low-carbohydrate diets on cardiovascular risk factors: a
meta-analysis</article-title>. <source>PLoS One</source>.
<year>2020</year>;<volume>15</volume>(<issue>1</issue>):<fpage>e0225348</fpage>.<pub-id pub-id-type="pmid">31935216</pub-id></mixed-citation>
              </ref>
              <ref id="bib29">
                <label>29.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huntriss</surname><given-names>R</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>M</given-names></string-name>, <string-name><surname>Bedwell</surname><given-names>C</given-names></string-name></person-group>.
<article-title>The interpretation and effect of a low-carbohydrate diet in the
management of type 2 diabetes: a systematic review and meta-analysis of randomised
controlled trials</article-title>. <source>Eur J Clin Nutr</source>.
<year>2018</year>;<volume>72</volume>(<issue>3</issue>):<fpage>311</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">29269890</pub-id></mixed-citation>
              </ref>
              <ref id="bib30">
                <label>30.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hyde</surname><given-names>PN</given-names></string-name>, <string-name><surname>Sapper</surname><given-names>TN</given-names></string-name>, <string-name><surname>Crabtree</surname><given-names>CD</given-names></string-name>, <string-name><surname>LaFountain</surname><given-names>RA</given-names></string-name>,
<string-name><surname>Bowling</surname><given-names>ML</given-names></string-name>, <string-name><surname>Buga</surname><given-names>A</given-names></string-name>, <string-name><surname>Fell</surname><given-names>B</given-names></string-name>, <string-name><surname>McSwiney</surname><given-names>FT</given-names></string-name>, <string-name><surname>Dickerson</surname><given-names>RM</given-names></string-name>, <string-name><surname>Miller</surname><given-names>VJ</given-names></string-name><etal>et
al.</etal></person-group><article-title>Dietary carbohydrate restriction improves metabolic syndrome independent of
weight loss</article-title>. <source>JCI Insight</source>.
<year>2019</year>;<volume>4</volume>(<issue>12</issue>):<fpage>e128308</fpage>.</mixed-citation>
              </ref>
              <ref id="bib31">
                <label>31.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Skytte</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Samkani</surname><given-names>A</given-names></string-name>, <string-name><surname>Petersen</surname><given-names>AD</given-names></string-name>, <string-name><surname>Thomsen</surname><given-names>MN</given-names></string-name>, <string-name><surname>Astrup</surname><given-names>A</given-names></string-name>, <string-name><surname>Chabanova</surname><given-names>E</given-names></string-name>, <string-name><surname>Frystyk</surname><given-names>J</given-names></string-name>, <string-name><surname>Holst</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Thomsen</surname><given-names>HS</given-names></string-name>, <string-name><surname>Madsbad</surname><given-names>S</given-names></string-name><etal>et
al.</etal></person-group><article-title>A carbohydrate-reduced high-protein diet improves HbA1c and liver fat
content in weight stable participants with type 2 diabetes: a randomised controlled
trial</article-title>. <source>Diabetologia</source>.
<year>2019</year>;<volume>62</volume>(<issue>11</issue>):<fpage>2066</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">31338545</pub-id></mixed-citation>
              </ref>
              <ref id="bib32">
                <label>32.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jenkins</surname><given-names>DJA</given-names></string-name>, <string-name><surname>Dehghan</surname><given-names>M</given-names></string-name>, <string-name><surname>Mente</surname><given-names>A</given-names></string-name>, <string-name><surname>Bangdiwala</surname><given-names>SI</given-names></string-name>,
<string-name><surname>Rangarajan</surname><given-names>S</given-names></string-name>,
<string-name><surname>Srichaikul</surname><given-names>K</given-names></string-name>,
<string-name><surname>Mohan</surname><given-names>V</given-names></string-name>, <string-name><surname>Avezum</surname><given-names>A</given-names></string-name>, <string-name><surname>Díaz</surname><given-names>R</given-names></string-name>, <string-name><surname>Rosengren</surname><given-names>A</given-names></string-name><etal>et
al.</etal></person-group><article-title>Glycemic index, glycemic load, and cardiovascular disease and
mortality</article-title>. <source>N Engl J Med</source>.
<year>2021</year>;<volume>384</volume>(<issue>14</issue>):<fpage>1312</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">33626252</pub-id></mixed-citation>
              </ref>
              <ref id="bib33">
                <label>33.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sackner-Bernstein</surname><given-names>J</given-names></string-name>, <string-name><surname>Kanter</surname><given-names>D</given-names></string-name>, <string-name><surname>Kaul</surname><given-names>S</given-names></string-name></person-group>.
<article-title>Dietary intervention for overweight and obese adults: comparison of
low-carbohydrate and low-fat diets. a meta-analysis</article-title>. <source>PLoS
One</source>.
<year>2015</year>;<volume>10</volume>(<issue>10</issue>):<fpage>e0139817</fpage>.<pub-id pub-id-type="pmid">26485706</pub-id></mixed-citation>
              </ref>
              <ref id="bib34">
                <label>34.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schwingshackl</surname><given-names>L</given-names></string-name>, <string-name><surname>Hoffmann</surname><given-names>G</given-names></string-name></person-group>.
<article-title>Comparison of effects of long-term low-fat vs high-fat diets on blood
lipid levels in overweight or obese patients: a systematic review and
meta-analysis</article-title>. <source>J Acad Nutr Diet</source>.
<year>2013</year>;<volume>113</volume>(<issue>12</issue>):<fpage>1640</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">24139973</pub-id></mixed-citation>
              </ref>
              <ref id="bib35">
                <label>35.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gjuladin-Hellon</surname><given-names>T</given-names></string-name>, <string-name><surname>Davies</surname><given-names>IG</given-names></string-name>, <string-name><surname>Penson</surname><given-names>P</given-names></string-name>, <string-name><surname>Amiri Baghbadorani</surname><given-names>R</given-names></string-name></person-group>.
<article-title>Effects of carbohydrate-restricted diets on low-density lipoprotein
cholesterol levels in overweight and obese adults: a systematic review and
meta-analysis</article-title>. <source>Nutr Rev</source>.
<year>2019</year>;<volume>77</volume>(<issue>3</issue>):<fpage>161</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">30544168</pub-id></mixed-citation>
              </ref>
              <ref id="bib36">
                <label>36.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shih</surname><given-names>CW</given-names></string-name>, <string-name><surname>Hauser</surname><given-names>ME</given-names></string-name>, <string-name><surname>Aronica</surname><given-names>L</given-names></string-name>, <string-name><surname>Rigdon</surname><given-names>J</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>CD</given-names></string-name></person-group>.
<article-title>Changes in blood lipid concentrations associated with changes in intake
of dietary saturated fat in the context of a healthy low-carbohydrate weight-loss diet:
a secondary analysis of the Diet Intervention Examining The Factors Interacting with
Treatment Success (DIETFITS) trial</article-title>. <source>Am J Clin Nutr</source>.
<year>2019</year>;<volume>109</volume>(<issue>2</issue>):<fpage>433</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">30649213</pub-id></mixed-citation>
              </ref>
              <ref id="bib37">
                <label>37.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goldberg</surname><given-names>IJ</given-names></string-name>, <string-name><surname>Ibrahim</surname><given-names>N</given-names></string-name>, <string-name><surname>Bredefeld</surname><given-names>C</given-names></string-name>, <string-name><surname>Foo</surname><given-names>S</given-names></string-name>,
<string-name><surname>Lim</surname><given-names>V</given-names></string-name>, <string-name><surname>Gutman</surname><given-names>D</given-names></string-name>, <string-name><surname>Huggins</surname><given-names>LA</given-names></string-name>, <string-name><surname>Hegele</surname><given-names>RA</given-names></string-name></person-group>.
<article-title>Ketogenic diets, not for everyone</article-title>. <source>J Clin
Lipidol</source>.
<year>2021</year>;<volume>15</volume>:<fpage>61</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">33191194</pub-id></mixed-citation>
              </ref>
              <ref id="bib38">
                <label>38.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Phinney</surname><given-names>SD</given-names></string-name>, <string-name><surname>Tang</surname><given-names>AB</given-names></string-name>, <string-name><surname>Waggoner</surname><given-names>CR</given-names></string-name>, <string-name><surname>Tezanos-Pinto</surname><given-names>RG</given-names></string-name>,
<string-name><surname>Davis</surname><given-names>PA</given-names></string-name></person-group>.
<article-title>The transient hypercholesterolemia of major weight loss</article-title>.
<source>Am J Clin Nutr</source>.
<year>1991</year>;<volume>53</volume>(<issue>6</issue>):<fpage>1404</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">2035468</pub-id></mixed-citation>
              </ref>
              <ref id="bib39">
                <label>39.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ballantyne</surname><given-names>CM</given-names></string-name>, <string-name><surname>Olsson</surname><given-names>AG</given-names></string-name>, <string-name><surname>Cook</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Mercuri</surname><given-names>MF</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>TR</given-names></string-name>, <string-name><surname>Kjekshus</surname><given-names>J</given-names></string-name></person-group>.
<article-title>Influence of low high-density lipoprotein cholesterol and elevated
triglyceride on coronary heart disease events and response to simvastatin therapy in
4S</article-title>. <source>Circulation</source>.
<year>2001</year>;<volume>104</volume>(<issue>25</issue>):<fpage>3046</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">11748098</pub-id></mixed-citation>
              </ref>
              <ref id="bib40">
                <label>40.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bartlett</surname><given-names>J</given-names></string-name>, <string-name><surname>Predazzi</surname><given-names>IM</given-names></string-name>,
<string-name><surname>Williams</surname><given-names>SM</given-names></string-name>,
<string-name><surname>Bush</surname><given-names>WS</given-names></string-name>, <string-name><surname>Kim</surname><given-names>Y</given-names></string-name>,
<string-name><surname>Havas</surname><given-names>S</given-names></string-name>, <string-name><surname>Toth</surname><given-names>PP</given-names></string-name>, <string-name><surname>Fazio</surname><given-names>S</given-names></string-name>, <string-name><surname>Miller</surname><given-names>M</given-names></string-name></person-group>.
<article-title>Is isolated low high-density lipoprotein cholesterol a cardiovascular
disease risk factor? New insights from the Framingham Offspring Study</article-title>.
<source>Circulation</source>.
<year>2016</year>;<volume>9</volume>(<issue>3</issue>):<fpage>206</fpage>–<lpage>12</lpage>.</mixed-citation>
              </ref>
              <ref id="bib41">
                <label>41.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jeppesen</surname><given-names>J</given-names></string-name>, <string-name><surname>Hein</surname><given-names>HO</given-names></string-name>, <string-name><surname>Suadicani</surname><given-names>P</given-names></string-name>, <string-name><surname>Gyntelberg</surname><given-names>F</given-names></string-name></person-group>.
<article-title>Low triglycerides-high high-density lipoprotein cholesterol and risk of
ischemic heart disease</article-title>. <source>Arch Intern Med</source>.
<year>2001</year>;<volume>161</volume>(<issue>3</issue>):<fpage>361</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">11176761</pub-id></mixed-citation>
              </ref>
              <ref id="bib42">
                <label>42.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eddy</surname><given-names>D</given-names></string-name>, <string-name><surname>Schlessinger</surname><given-names>L</given-names></string-name>,
<string-name><surname>Kahn</surname><given-names>R</given-names></string-name>, <string-name><surname>Peskin</surname><given-names>B</given-names></string-name>, <string-name><surname>Schiebinger</surname><given-names>R</given-names></string-name></person-group>.
<article-title>Relationship of insulin resistance and related metabolic variables to
coronary artery disease: a mathematical analysis</article-title>. <source>Diabetes
Care</source>.
<year>2009</year>;<volume>32</volume>(<issue>2</issue>):<fpage>361</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">19017770</pub-id></mixed-citation>
              </ref>
              <ref id="bib43">
                <label>43.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Falkenhain</surname><given-names>K</given-names></string-name>, <string-name><surname>Locke</surname><given-names>SR</given-names></string-name>, <string-name><surname>Lowe</surname><given-names>DA</given-names></string-name>, <string-name><surname>Reitsma</surname><given-names>NJ</given-names></string-name>, <string-name><surname>Lee</surname><given-names>T</given-names></string-name>,
<string-name><surname>Singer</surname><given-names>J</given-names></string-name>, <string-name><surname>Weiss</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Little</surname><given-names>JP</given-names></string-name></person-group>.
<article-title>Keyto app and device versus WW app on weight loss and metabolic risk in
adults with overweight or obesity: a randomized trial</article-title>.
<source>Obesity</source>. <comment>[Internet]</comment><year>2021</year>.
<comment>doi:10.1002/oby.23242</comment>.</mixed-citation>
              </ref>
              <ref id="bib44">
                <label>44.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoong</surname><given-names>CWS</given-names></string-name>, <string-name><surname>Hussain</surname><given-names>I</given-names></string-name>, <string-name><surname>Aravamudan</surname><given-names>VM</given-names></string-name>,
<string-name><surname>Phyu</surname><given-names>EE</given-names></string-name>, <string-name><surname>Lin</surname><given-names>JHX</given-names></string-name>, <string-name><surname>Koh</surname><given-names>H</given-names></string-name></person-group>.
<article-title>Obesity is associated with poor Covid-19 outcomes: a systematic review
and meta-analysis</article-title>. <source>Horm Metab Res</source>.
<year>2021</year>;<volume>53</volume>(<issue>2</issue>):<fpage>85</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">33395706</pub-id></mixed-citation>
              </ref>
              <ref id="bib45">
                <label>45.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Malik</surname><given-names>P</given-names></string-name>, <string-name><surname>Patel</surname><given-names>U</given-names></string-name>, <string-name><surname>Patel</surname><given-names>K</given-names></string-name>, <string-name><surname>Martin</surname><given-names>M</given-names></string-name>, <string-name><surname>Shah</surname><given-names>C</given-names></string-name>, <string-name><surname>Mehta</surname><given-names>D</given-names></string-name>, <string-name><surname>Malik</surname><given-names>FA</given-names></string-name>, <string-name><surname>Sharma</surname><given-names>A</given-names></string-name></person-group>.
<article-title>Obesity a predictor of outcomes of COVID-19 hospitalized patients—a
systematic review and meta-analysis</article-title>. <source>J Med Virol</source>.
<year>2021</year>;<volume>93</volume>(<issue>2</issue>):<fpage>1188</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">32975814</pub-id></mixed-citation>
              </ref>
              <ref id="bib46">
                <label>46.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name><surname>Hu</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>C</given-names></string-name></person-group>.
<article-title>Obesity aggravates COVID-19: a systematic review and
meta-analysis</article-title>. <source>J Med Virol</source>.
<year>2021</year>;<volume>93</volume>(<issue>1</issue>):<fpage>257</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">32603481</pub-id></mixed-citation>
              </ref>
              <ref id="bib47">
                <label>47.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bansal</surname><given-names>R</given-names></string-name>, <string-name><surname>Gubbi</surname><given-names>S</given-names></string-name>, <string-name><surname>Muniyappa</surname><given-names>R</given-names></string-name></person-group>.
<article-title>Metabolic syndrome and COVID 19: endocrine-immune-vascular interactions
shapes clinical course</article-title>. <source>Endocrinology</source>.
<year>2020</year>;<volume>161</volume>(<issue>10</issue>):<fpage>bqaa112</fpage>.<pub-id pub-id-type="pmid">32603424</pub-id></mixed-citation>
              </ref>
              <ref id="bib48">
                <label>48.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Santos</surname><given-names>A</given-names></string-name>, <string-name><surname>Magro</surname><given-names>DO</given-names></string-name>, <string-name><surname>Evangelista-Poderoso</surname><given-names>R</given-names></string-name>,
<string-name><surname>Saad</surname><given-names>MJA</given-names></string-name></person-group>.
<article-title>Diabetes, obesity, and insulin resistance in COVID-19: molecular
interrelationship and therapeutic implications</article-title>. <source>Diabetol Metab
Syndr</source>.
<year>2021</year>;<volume>13</volume>(<issue>1</issue>):<fpage>23</fpage>.<pub-id pub-id-type="pmid">33648564</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
